3rd Gen Painting & Remodeling TOP JOB Win

Madison, WI – 3rd Gen Painting & Remodeling was recently named by American Painting Contractor (APC) Magazine as the winner of the 2020 TOP JOB Madison, WI. TOP JOB honors a single painting company in a city or town for its superior work and commitment to excellence in the painting industry.

APC is the national magazine published for painting contractors, and the TOP JOB Awards are sponsored by top manufacturers such as Zinsser, Sherwin-Williams, Graco and Federated Insurance.

APC’s TOP JOB Awards is in its 22^nd year of recognizing painting contractors who go above and beyond for their clients and industry. The APC staff judges the entries and selects the winners based on craftsmanship, technique and creativity as well as the contractor’s ability to overcome challenges, communicate with clients and deliver an excellent finished product.

Judges noted on this outstanding job “Intricate Queen Anne style details, challenging color change, exemplifies the craft of exterior painting” one of the judges noted.

Each winner will be featured in a full-page article about their company and TOP JOB in the April issue and on www.paintmag.com releasing April 21st­­­­, 2020.

About APC
American Painting Contractor is the #1 resource for painting contractors. For over 90 years, APC has been the source for application techniques, new products, business strategies and news. More information about the publication can be found on their site at www.paintmag.com.

About 3rd Gen Painting & Remodeling

Concurrently, the 3rd Generation name stands as an evolution from the typical painting or remodeling contractor. Simply put, 3rd Gen Painting looks to completely disrupt the status quo in the contracting industry.

The company aims to provide a new level of customer service and phase the “business as usual” tactics employed by the typical painting or remodeling contractor. 3rd Gen’s award-winning system is tailored around the customer experience and provides unmatched value to our customer & employees alike. 2018 was a marquee year for us and we are excited for you to experience the 3rd Gen difference in 2019 and beyond!

###

Anytime Fitness Providing Daily Support for Local Communities During Safer at Home Extension

Area gyms encouraging us to stay active with an online accountability group while supporting local businesses

SOUTHERN WISCONSIN (April 30, 2020) – With the recent extension of Wisconsin’s Safer at Home order, it is unclear when gyms in Wisconsin will be able to reopen. In the meantime, Anytime Fitness of Southern Wisconsin is offering Wisconsinites virtual support to stay connected and on track with their health goals. Andy Gundlach, owner of the 33 locations that make up Anytime Fitness of Southern Wisconsin, started the Anytime Fitness Healthy at Home Challenge Facebook group in March to encourage members of the community to continue their fitness routine while abiding by the Safer at Home order. Gundlach’s team posts a daily workout to the group, and participants are encouraged to share a sweaty selfie for the chance to win a prize that supports local businesses in their communities. Since the group begin, it has grown to include more than 1300 members and has awarded $500 worth of local gift cards to prize winners.

Under Safer at Home, going to the gym is off-limits, yet most people would benefit from keeping their regular exercise routine, especially in times of high stress. “Regular movement and exercise can help decrease stress, improve your mood, and encourage better sleep. In times of uncertainty, like what we’re currently experiencing, it is essential to implement movement into your daily routine,” says Ryan Campbell, Training Specialist for Anytime Fitness of Southern Wisconsin. To that end, Anytime Fitness of Southern Wisconsin is posting daily workouts that can be done at home with little to no equipment. New workouts are posted seven days a week, and participants can also browse and select from more than 45 previous workouts available in the Facebook group.

“Lots of health clubs out there are offering at-home workouts or virtual training in response to the need to temporarily close due to COVID-19,” Gundlach explained. “What makes this group unique is the community aspect. It’s more than just a daily workout; it’s the support, motivation, accountability, and encouragement from your teammates. It gives a sense of normalcy in this unprecedented time in which we are living.”

Gundlach is also offering a weekly prize, drawn at random, to someone who posts an after-workout selfie. As a small business owner, Gundlach understands the importance of supporting local businesses. Each week he purchases $100 in gift cards to local businesses of the winner’s choice for the winner. Since the prize drawings began, there have been five winners who have supported businesses like J&D Care Care LLC of Janesville, WI, Vince’s Pizza and Pancho and Lefty’s of Monroe, WI, Java Cat of Madison, WI, and Rosie’s Coffee Bar and Bakery and Monona Bakery and Eatery of Monona, WI among others.

People are sharing more than just their #sweatyselfies for their chance to win a prize. Pets and kids are cheerleaders and workout buddies. Laundry detergent, jugs of cat litter, and cases of beer are substitutes for weights. Group members are finding time for the daily workouts and establishing new at-home routines, and the overwhelming sense of community and togetherness underlies the entire group. Comments such as, “I am grateful for this support page to hear others are also struggling with working out at home….makes me feel better and normal. I miss the gym so much!” (Kelly M.) and “With all the support and positive attitudes and just wanting to stay healthy, it’s not like being at the gym but everybody here is wonderful and I just wanna say thank you,” (Katherine D.) reiterate the importance of community at this time, even if can only be online and not at the gym.

To join the Anytime Fitness Healthy at Home Challenge Facebook group, search for “Anytime Fitness Healthy at Home Challenge” on Facebook. This group is open to the public. You do not need to be a member at Anytime Fitness to join. For more information on Anytime Fitness, please visit www.anytimefitness.com or email afcustomercare@gmail.com.

About Anytime Fitness of Southern Wisconsin

We get the health and fitness industry can be confusing and overwhelming, which is why we offer you a free consultation and free personal training experience to learn how to become healthier. Our trainers have helped thousands of people in Southern Wisconsin get healthier and happier by taking the guess work out of achieving their goals. Don’t change who you are to fit in at a different gym; come to Anytime Fitness and be YOU, healthy and happy.

Nominate a hero for the WPS Military Salute Award

FOR IMMEDIATE RELEASE

Contact:
DeAnne Boegli, Director of Communications
608-977-7343
deanne.boegli@wpsic.com

Nominate a hero for the WPS Military Salute Award

MADISON, Wis.—May 4, 2020—America’s active-duty military and veteran doctors, nurses, public safety professionals, and others are helping their communities get through the challenging days of the COVID-19 pandemic.

In recognition of their efforts, WPS Health Solutions is announcing the WPS Military Salute Award, with a $1,000 prize to be donated to the winner’s charity of choice that is assisting in the fight against COVID-19.

Nominations are being accepted through June 1, 2020. To nominate a service member or veteran, go to wpshealthsolutions.com/military-salute and complete the form along with a nomination statement of 250-500 words.

“During these difficult times, it is important to find, appreciate, and recognize the good. Whether someone is fighting the battle at the hospital, working to develop a vaccine, or volunteering at the local food pantry, there are heroes all around us. WPS is proud to honor them with this award and support their charity of choice,” says Megan Willauer, Director of Events and Strategic Partnerships.

The winner will be determined by a committee of WPS employees. Submitted statements may be used in social media mentions, on the WPS Military Salute website, and in other marketing materials. Employees of Wisconsin Physicians Service Insurance Corporation (WPS) and its subsidiaries are not eligible to participate.

About WPS Health Solutions

WPS Health Solutions is a nationally regarded government contractor and a leading Wisconsin not-for-profit health insurer. The WPS Health Insurance division offers affordable health plans and benefits administration. The WPS Government Health Administrators division administers Part A and B Medicare benefits for millions of seniors in multiple states, and the WPS Military and Veterans Health division serves millions more members who are active in the U.S. military, veterans, and their families. Wisconsin Physicians Service Insurance Corporation (WPS Health Solutions) has been based in Madison, Wis., for more than 70 years. For more information, please visit wpshealthsolutions.com.

Arcturus Therapeutics and Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 Vaccine

San Diego, CA and Somerset, NJ, May 4, 2020 (GLOBE NEWSWIRE) – Arcturus Therapeutics Holdings Inc. (“Arcturus”, “the Company”, Nasdaq: ARCT), a leading clinical-stage messenger RNA (mRNA) medicines and vaccines company, and Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced a partnership to support the expected manufacture of Arcturus’ COVID-19 mRNA vaccine candidate (LUNAR-COV19), intended to protect against the SARS-CoV-2 coronavirus.

LUNAR-COV19 utilizes Arcturus’ self-transcribing and replicating mRNA (STARR™) technology and the Company’s LUNAR® lipid-mediated delivery to produce an extraordinarily low dose, potential single shot COVID-19 vaccine.

The manufacture of LUNAR-COV19 at Catalent’s state-of-the-art drug substance biomanufacturing facility in Madison, Wisconsin will support human clinical studies and, if successful, commercialization of the vaccine. The COVID-19 vaccine program will take advantage of the facility’s flex-suite, a cGMP manufacturing suite that can produce batches at multiple scales and support Arcturus’ proprietary mRNA manufacturing process.

The partnership will combine Arcturus’ low-dose STARR™ mRNA vaccine technology with Catalent’s scalable cGMP manufacturing capabilities to produce millions of doses of LUNAR-COV19 mRNA in 2020 and potentially 100s of millions of doses annually for worldwide use. Preparations for this program have already begun at the Madison facility, and both organizations are committed to meeting the global demand on unprecedented manufacturing timelines. Technology transfer will be completed this month and manufacture of the first cGMP batches of LUNAR-COV19 mRNA are expected to be completed by June 2020.

“Catalent is proud to partner with Arcturus in the pursuit of a vaccine that could protect people against the coronavirus pandemic,” said John Chiminski, Chair and Chief Executive Officer of Catalent. “Our unique experience and flex-suite cGMP capacity will enable rapid scale-up of Arcturus’ proprietary manufacturing process to make the vaccine available as soon as possible.”

Joseph Payne, President & CEO of Arcturus, stated, “Government agencies and foundations are securing rights and access to vaccines being developed to protect their respective populations. The Catalent Biologics team and their high-tech Madison facility is ideally suited to manufacture a substantial number of doses.  Arcturus will be better positioned to supply these entities with our COVID-19 vaccine candidate on an accelerated basis with Catalent as our manufacturing partner.”

STARR™ and LUNAR® are trademarks of Arcturus Therapeutics.

ABOUT ARCTURUS THERAPEUTICS

Founded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT) is a clinical-stage mRNA medicines and vaccines company with enabling technologies: (i) LUNAR® lipid-mediated delivery, (ii) STARR™ mRNA Technology and (iii) mRNA drug substance along with drug product manufacturing expertise. Arcturus’ diverse pipeline of RNA therapeutic candidates includes programs to potentially treat Ornithine Transcarbamylase (OTC) Deficiency, Cystic Fibrosis, Glycogen Storage Disease Type 3, Hepatitis B, non-alcoholic steatohepatitis (NASH) and a self-replicating mRNA vaccine for SARS-CoV-2. Arcturus’ versatile RNA therapeutics platforms can be applied toward multiple types of nucleic acid medicines including messenger RNA, small interfering RNA, replicon RNA, antisense RNA, microRNA, DNA, and gene editing therapeutics. Arcturus’ technologies are covered by its extensive patent portfolio (187 patents and patent applications, issued in the U.S., Europe, Japan, China and other countries). Arcturus’ commitment to the development of novel RNA therapeutics has led to collaborations with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, Ultragenyx Pharmaceutical, Inc., Takeda Pharmaceutical Company Limited, CureVac AG, Synthetic Genomics Inc., Duke-NUS, and the Cystic Fibrosis Foundation. For more information visit www.ArcturusRx.com

​ABOUT CATALENT BIOLOGICS

Catalent Biologics is a global leader in development, manufacturing and analytical services for new biological entities, cell and gene therapies, biosimilars, sterile injectables, and antibody-drug conjugates. With over 20 years of proven expertise, Catalent Biologics has worked with 600+ mAbs and 80+ proteins, produced 13 biopharmaceutical drugs using GPEx® cell line development technology, and 35+ commercially approved products. Catalent has recently acquired MaSTherCell, a technology-focused cell therapy development and manufacturing partner with expertise in autologous and allogeneic cell therapy that complements Catalent’s industry-leading expertise and commercial success in gene therapy development, manufacturing and adeno-associated virus (AAV) vector production. Together, Paragon Gene Therapy and MaSTherCell have produced over 100 GMP batches across 60+ clinical and commercial programs. For more information on Catalent Biologics, visit www.catalent.com/biologics

ABOUT CATALENT

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs over 13,500 people, including over 2,400 scientists and technicians, at more than 40 facilities, and in fiscal year 2019 generated over $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com

MORE PRODUCTS. BETTER TREATMENTS. RELIABLY SUPPLIED.™

ARCTURUS FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements that involve substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. Any statements, other than statements of historical fact included in this press release, including those regarding the Company’s expected performance, the Company’s development of any specific novel mRNA therapeutics, the Company’s efforts to develop a vaccine against COVID-19 based on the Company’s mRNA therapeutics, the forecasted safety, efficacy or reliability of a vaccine against COVID-19,were one to be successfully developed based on the Company’s mRNA therapeutics, the timing and availability of a vaccine against COVID-19 were one to be successfully developed based on the Company’s mRNA therapeutics, the potential initiation of human trials of a vaccine against COVID-19 based on the Company’s mRNA therapeutics, the timing of initiation of human trials of a vaccine against COVID-19 based on the Company’s mRNA therapeutics, the ability of any product to receive regulatory approval in Singapore and whether or not any other countries will accept the trials conducted in that jurisdiction, the potential market impact of a vaccine against COVID-19 based on the Company’s mRNA therapeutics, the potential manufacturing capabilities of the Company’s partnership with Catalent, the timing of technology transfer related to the Company’s partnership with Catalent, the manufacture of GMP batches of a vaccine against COVID-19, were one to be successfully developed based on the Company’s mRNA therapeutics, any expected benefit from the Company’s partnership with Catalent and timing of any benefits related thereto and the impact of general business and economic conditions are forward-looking statements. Arcturus may not actually achieve the plans, carry out the intentions or meet the expectations or projections disclosed in any forward-looking statements such as the foregoing and you should not place undue reliance on such forward-looking statements. Such statements are based on management’s current expectations and involve risks and uncertainties, including those discussed under the heading “Risk Factors” in Arcturus’ Annual Report on Form 10-K for the fiscal year ended December 31, 2019, filed with the SEC on March 16, 2020 and in subsequent filings with, or submissions to, the SEC. No assurances can be given that any results reported in pre-clinical studies can be replicated in further studies or in human beings, or that a vaccine can or will ever be developed or approved using the Company’s technology. Except as otherwise required by law, Arcturus disclaims any intention or obligation to update or revise any forward-looking statements, which speak only as of the date they were made, whether as a result of new information, future events or circumstances or otherwise.

CATALENT FORWARD-LOOKING STATEMENT NOTICE

Statements concerning the development, success and administration of clinical trials, ability to launch and future manufacturing contained in this release are forward-looking statements. They involve known and unknown risks, uncertainties, and other factors that may cause actual results or performance to be different from those expressed or implied in this release. Catalent has based its forward-looking statements on its current expectations, assumptions, estimates and projections, which it believes to be reasonable, but various factors, including factors beyond Catalent’s control, may affect future results or performance. Among the factors that may affect these forward-looking statements are: the rapidly changing market for treatments and vaccines to address the COVID-19 pandemic, the current or future effects of the COVID-19 pandemic, including its effects on Catalent’s and its clients’ businesses, the outcome of the development of this or any competing vaccine or any treatment for COVID-19, the outcome of any and all reviews, inspections or other approvals by the U.S. Food and Drug Administration (FDA) or similar regulatory health authority, customer and payor acceptance of the proposed vaccine, any competing vaccine, or any treatment for COVID-19, competitor responses to a potential future launch of this vaccine, changes to the overall economic climate in the United States or among potential purchasers of the product, changes to the healthcare reimbursement system in the United States or elsewhere, competing initiatives at Catalent or Arcturus, supply chain risks relating to the vaccine, fluctuations in currency exchange rates that affect Catalent’s ability to source the materials needed for the production of the product, or potential third-party claims or litigation related to the vaccine. These and other important factors, including those discussed under “Risk Factors” in the Catalent, Inc. Annual Report on Form 10-K for the year ended June 30, 2019, may affect future results or performance. Catalent makes the statements in this release only as of the date of this release, and Catalent disclaims any duty, except as required by law, to update or revise any forward-looking statement, regardless of the circumstances.

ARCTURUS INVESTOR AND MEDIA CONTACTS

Neda Safarzadeh
(858) 900-2682
IR@ArcturusRx.com

Carlo Tanzi, Ph.D.
Kendall Investor Relations
(617) 914-0008
ctanzi@kendallir.com

CATALENT MEDIA CONTACTS

Chris Halling
+44 (0)7580 041073
chris.halling@catalent.com

Richard Kerns
+44 (0) 161 728 5880
richard@nepr.agency

CATALENT INVESTOR CONTACT

Paul Surdez
+1 (732) 537-6325
investors@catalent.com

WPS Health Solutions publishes new Corporate Citizenship Report

FOR IMMEDIATE RELEASE

Contact:
DeAnne Boegli, Director of Communications
608-977-7343
deanne.boegli@wpsic.com

WPS Health Solutions publishes new Corporate Citizenship Report

MADISON, Wis.—April 30, 2020—The 2019 WPS Health Solutions Corporate Citizenship Report is now available on the company’s website. The report provides a comprehensive overview of the major lines of business at WPS, with a special emphasis on the company’s ethical culture, labor practices, community support, environmental stewardship, and awards and recognition.

“The report highlights how WPS Health Solutions is making a difference in the lives of our customers, employees, the environment, and the communities we serve,” says Jane Keller-Allen, Vice President of Internal Audit, Compliance and Risk. “It allows us to showcase our employees’ high ethical standards and WPS’ commitment to conducting business with integrity.  It allows anyone who is curious about WPS to get to know us a little better.”

“Leading the Healthy Conversation” is the theme for the 2019 report. More than 70 years since its founding, WPS Health Solutions leads the healthy conversation for the health and financial protection of its customers with three lines of business: WPS Health Insurance, WPS Government Health Administrators, and WPS Military and Veterans Health, as well as two subsidiaries: Arise Health Plan and EPIC Specialty Benefits.

Employees of WPS Health Solutions aspire to do their best by exhibiting the company’s four core values: Individual Responsibility, Customer Focused, Mutual Respect, and Driven and Passionate. Visual and interactive displays reinforce the message at all WPS locations.

The mission of WPS Health Solutions is simply this: to provide health insurance and benefit plan administration to private and government customers with service and value considered by our customers to be the very best.

From a facilities standpoint, the report describes how WPS Health Solutions is recognized as a leader in environmental sustainability. In 2019, the company completed 10 major energy-efficiency initiatives. Projects included relocating two of its office locations and installing LED lighting conversions at various WPS facilities. The company also improved air-handling efficiency and climate controls. The company’s Madison campus alone saved more than $119,000 on utility bills in 2019. More importantly, this energy reduction is equivalent to 1,527 tons of carbon dioxide emissions.

The report can be found at wpshealthsolutions.com > About > Learn About WPS Health Solutions.

About WPS Health Solutions

WPS Health Solutions is a nationally regarded government contractor and a leading Wisconsin not-for-profit health insurer. The WPS Health Insurance division offers affordable health plans and benefits administration. The WPS Government Health Administrators division administers Part A and B Medicare benefits for millions of seniors in multiple states, and the WPS Military and Veterans Health division serves millions more members who are active in the U.S. military, veterans, and their families. Wisconsin Physicians Service Insurance Corporation (WPS Health Solutions) has been based in Madison, Wis., for more than 70 years. For more information, please visit wpshealthsolutions.com.